Skip to main content

Table 1 Demographics of the 120 patients with CGEJ

From: Transhiatal esophagectomy as a treatment for locally advanced adenocarcinoma of the gastroesophageal junction: postoperative and oncologic results of a single-center cohort

Clinicopathologic factor

Overall cohort, no. (%)

Sex

 - Male

105 (87.5%)

 - Female

15 (12.5%)

Age, yearsa

64 (26-81)

BMI, kg/m2a

25 (15.6-37)

Malnutrition

54 (45%)

ASA score

 - 1

15 (12.5%)

 - 2

92 (76.7%)

 - 3

13 (10.8%)

One or more comorbidities

 - Cardiac

54 (45%)

 - Vascular

17 (14.2%)

 - Pulmonary

22 (18.3%)

 - Diabetes mellitus

8 (6.7%)

Smoking history

84 (70%)

Reflux history

28 (23.3%)

Preoperative Siewert classification

 - I

63 (52.5%)

 - II

54 (45%)

 - III

3 (2.5%)

Pretreatment T stage

 - cT2

6 (5%)

 - cT3

110 (91.7%)

 - cT4

4 (3.3%)

Pretreatment N stage

 - cN0

24 (20%)

 - cN+

96 (80%)

Preoperative treatment

 - Chemotherapy

56 (46.7%)

 - Chemo-radiotherapy

64 (53.3%)

  1. ASA American Society of Anesthesiologists, BMI body mass index, CGEJ locally advanced cancer of the gastroesophageal junction, c clinical stage
  2. aExpressed as median (range)